Radiopharm Theranostics Ltd (RADX) Current Assets (2024 - 2025)
Radiopharm Theranostics (RADX) posted quarterly Current Assets of $255238.2 for Q2 2025, up 69.51% year-over-year from $150575.6 in Q2 2024, and up 69.51% quarter-over-quarter from $150575.6 in Q2 2024.
Radiopharm Theranostics Ltd (RADX) Current Assets (2024 - 2025) Analysis & Trends
Radiopharm Theranostics (RADX) has reported Current Assets for 2 consecutive years, with $255238.2 the latest figure, recorded in Q2 2025.
- In Q2 2025, Current Assets rose 69.51% year-over-year to $255238.2; the TTM figure through Jun 2025 stood at $255238.2 (up 69.51% YoY), while the FY2025 annual figure was $39.9 million, up 1229.53% from the prior year.
- Current Assets rose to $255238.2 in Q2 2025 per RADX's latest filing, from $150575.6 in the prior quarter.
- Across five years, Current Assets topped out at $255238.2 in Q2 2025 and bottomed at $150575.6 in Q2 2024.
Powered by 
Peer Comparison
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2025 | 255,238.17 |
| Jun 30, 2024 | 150,575.63 |